Liver Cancer

Showing 1 - 25 of 435

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Collection of Blood From Patients With Cancer

Recruiting
  • Prostate Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

    Not yet recruiting
    • Cholangiocarcinoma
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Subjects Previously Enrolled in Poxviral Vector Gene Transfer

    Recruiting
    • Prostate Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 19, 2022

      Multi-analyte Blood Test Clinical Trial

      Recruiting
      • Liver Cirrhosis
      • +3 more
      • Multi-analyte Blood Test
      • Mission Hills, California
      • +6 more
      Aug 16, 2022

      Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

      Recruiting
      • Advanced Solid Tumor
      • +13 more
      • Duarte, California
      • +2 more
      Aug 16, 2022

      Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)

      Recruiting
      • Hepatoblastoma
      • +5 more
      • ET140203 T Cells
      • Boston, Massachusetts
        Dana-Farber/Boston Children's Cancer and Blood Disorders Center
      Aug 12, 2022

      Liver Cancer Trial in Durham (Quality of life questionnaires)

      Recruiting
      • Liver Cancer
      • Quality of life questionnaires
      • Durham, North Carolina
      • +1 more
      Aug 10, 2022

      Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +6 more
      • San Antonio, Texas
        Next Oncology
      Aug 9, 2022

      Intestinal Microbiome, Oral Microbiome, and Whole Blood

      Recruiting
      • Gastrointestinal Cancer
      • +6 more
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Aug 5, 2022

        Liver Cancer, Cancer, Treatment-Related Trial (Additional margin coagulation)

        Not yet recruiting
        • Liver Cancer
        • Cancer, Treatment-Related
        • Additional margin coagulation
        • (no location specified)
        Aug 5, 2022

        Lung Cancer, Liver Cancer, Breast Cancer Trial in Halifax (CBCT Imaging)

        Not yet recruiting
        • Lung Cancer
        • +3 more
        • CBCT Imaging
        • Halifax, Nova Scotia, Canada
          Nova Scotia Health (QEII)
        Aug 3, 2022

        Minimally Invasive and Open Liver Surgery in Different

        Active, not recruiting
        • Liver Cancer
        • +2 more
        • Minimally invasive liver resection
        • Brescia, Italy
          Fondazione Poliambulanza Istituto Ospedaliero
        Jul 22, 2022

        Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

        Completed
        • Hepatocellular Carcinoma
        • +2 more
        • Hong Kong, Hong Kong
          Queen Mary Hospital
        Jul 20, 2022

        Esophageal Cancer, Kidney Cancer, Larynx Cancer Trial in Saint Louis (Balloon-tipped catheter)

        Not yet recruiting
        • Esophageal Cancer
        • +12 more
        • Balloon-tipped catheter
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jul 19, 2022

        Breast Cancer, Liver Cancer, Prostate Cancer Trial in Bronx, New York (Clinical trial match-list, Match-list intervention)

        Not yet recruiting
        • Breast Cancer
        • +2 more
        • Clinical trial match-list
        • Match-list intervention
        • Bronx, New York
        • +2 more
        Jul 20, 2022

        Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer Trial in Changsha (Microwave ablation, Lenvatinib)

        Recruiting
        • Hepatocellular Carcinoma
        • +4 more
        • Changsha, Hunan, China
          Hunan Provincial People's Hospital
        Jul 8, 2022

        Hepatocellular Carcinoma(HCC) After Systemic Treatments

        Enrolling by invitation
        • Liver Cancer
        • +4 more
        • questionnaire survey
        • Wenzhou, Zhejiang, China
          Gang Chen
        Jul 1, 2022

        Prostate Cancer, Recurrent Adenocarcinoma, Liver Cancer Trial in Boston (MRI Simulator, Radiation Therapy)

        Recruiting
        • Prostate Cancer
        • +3 more
        • MRI Simulator
        • Radiation Therapy
        • Boston, Massachusetts
        • +1 more
        Jul 4, 2022

        Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

        Recruiting
        • Hepatocellular Carcinoma
        • +3 more
        • ET140203 autologous T cell product
        • Duarte, California
        • +3 more
        Jul 1, 2022

        Utilization of MAsS in Patients Undergoing LT for HCC

        Recruiting
        • NAFLD
        • +5 more
          • New York, New York
            Columbia University Irving Medical Center
          Jun 29, 2022

          Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

          Enrolling by invitation
          • Liver Cancer
          • Sarcopenia
          • gait speed; ct scan; grip strength and chair stand test
          • Wenzhou, Zhejiang, China
            Gang Chen
          Jun 29, 2022

          Deep Learning Model for the Prediction of Post-LT HCC Recurrence

          Completed
          • Liver Transplant Disorder
          • +2 more
          • Liver transplantation
          • Rome, RM, Italy
            Quirino Lai
          Jun 27, 2022

          Gastric Cancer, Pancreatic Cancer, Liver Cancer Trial in Xiamen (18F-FDG, 18F-AlF-FAPI PET/CT)

          Recruiting
          • Gastric Cancer
          • +2 more
          • 18F-FDG, 18F-AlF-FAPI PET/CT
          • Xiamen, Fujian, China
            The First affiliated hospital of xiamen university
          Jun 20, 2022

          Liver Cancer, Sarcopenia Trial in Wenzhou (gait speed; ct scan;grip strength and chair stand test)

          Enrolling by invitation
          • Liver Cancer
          • Sarcopenia
          • gait speed; ct scan;grip strength and chair stand test
          • Wenzhou, Zhejiang, China
            Gang Chen
          Jun 14, 2022